Obermatt
See Similar Stocks →

Pharmicell

KSC:005690 · KR7005690003
BiotechnologySmall

360° View

35
Price/Sales24
Price/Earnings34
Price/Book27
Dividend Yield79
Revenue Growth3
Profit Growth51
Capital Growth8
TSR 52w60
Leverage73
Liquidity15
Refinancing21
Combined11
Analyst Opinions32
Pro Holdings66
Opinion Changes50
Market Pulse96

Profile

CountrySouth Korea
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeKOSE
Employees12
Websitepharmicell.com
ISINKR7005690003
Last UpdateApr 2, 2026
Index & Theme
Stem Cell TherapyCardiovascularHematologyBiotechnologyHealth CareManufacturing

Description

Analysis

Pharmicell's 360° View rank of 35 places it below its peer average — better than 35% of its true peers.

It's lagging on growth (15) and on the expensive side (41). On safety it is highly leveraged (23), and the market shows favorable sentiment (74). Taken together, its Combined rank of 11 reads as among the weakest overall.

360° rank · history

1007550250
35
2026

All-time high

35

Jun 2026

All-time low

11

Mar 2026

Average rank

23

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
24
—
—
—
Price/Earnings
34
—
—
—
Price/Book
27
—
—
—
Dividend Yield
79
—
—
—
Value (overall)
41
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Pharmicell with its peers
Samsung Publishing
KSC:068290
42
CountrySouth Korea
IndustryMedia
SizeSmall
Full Stock Analysis →
Neuren Pharmaceuticals
ASX:NEU
29
CountryAustralia
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
KyungIn Synthetic
KSC:012610
23
CountrySouth Korea
IndustryChemicals
SizeX-Small
Full Stock Analysis →
KPX
KSC:092230
54
CountrySouth Korea
IndustryChemicals
SizeSmall
Full Stock Analysis →
KTCS
KSC:058850
62
CountrySouth Korea
IndustryCommercial Services & Supplies
SizeSmall
Full Stock Analysis →
Prenetics Global
NMQ:PRE
52
CountryHong Kong SAR China
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →